Payless has suffered from staggering debt and declining sales in a challenging retail landscape. (Photographer: Daniel Acker/Bloomberg)
Payless ShoeSource has become the most recent retailer to file for bankruptcy in the face of hard times.
The discount shoe store sought Chapter 11 bankruptcy protection on Tuesday, saying it needed to shore up its balance sheet in order to position itself for long-term survival in an increasingly tough retail landscape.
“This is a difficult, but necessary, decision driven by the continued challenges of the retail environment, which will only intensify,” said Payless CEO W. Paul Jones in a statement.
Payless plans to immediately close 400 stores in the U.S. and Puerto Rico and will also “aggressively manage” the rest of its real estate portfolio. That will mean closing additional stores and seeking to modify existing lease terms. The retailer currently has 4,400 stores in more than 30 countries.
Hot Bank Stocks To Invest In Right Now: Medical Marijuana, Inc. (MJNA)
- [By Peter Graham]
A long term performance chart shows GW Pharmaceuticals PLC outperforming other small cap marijuana stocks like Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA), but that outperformance has come withconsiderable volatility:
- [By Peter Graham]
A long term performance chart shows GW Pharmaceuticals PLC outperforming other marijuana stocks like Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA), but shares are also once again falling off from all-time highs:
- [By Sean Williams]
This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.
GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%
As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!
- [By Jim Robertson]
When investors think of cannabinoid or marijuana stocks, they either think of better known stocks likeGW Pharmaceuticals PLC (NASDAQ: GWPH)and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) that trade on bigger exchanges orCannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA) that are stilllisted on the OTC. However, there are other more indirect ways to invest in growing cannabinoid or marijuana acceptance.
- [By Keith Speights]
As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?
Hot Bank Stocks To Invest In Right Now: Canadian Solar Inc.(CSIQ)
- [By Elizabeth Balboa]
First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.
- [By Lisa Levin]
Some of the stocks that may grab investor focus today are:
Wall Street expects General Mills, Inc. (NYSE: GIS) to report quarterly earnings at $0.71 per share on revenue of $3.84 billion before the opening bell. General Mills shares gained 0.51 percent to $60.57 in after-hours trading.
Analysts expect FedEx Corporation (NYSE: FDX) to post quarterly earnings at $2.62 per share on revenue of $15.00 billion after the closing bell. FedEx shares gained 0.12 percent to $192.51 in after-hours trading.
Before the markets open, Canadian Solar Inc. (NASDAQ: CSIQ) is projected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million. Canadian Solar shares fell 0.44 percent to $13.49 in after-hours trading.
Analysts are expecting Nike Inc (NYSE: NKE) to have earned $0.53 per share on revenue of $8.47 billion in the latest quarter. Nike will release earnings after the markets close. Nike shares rose 0.14 percent to $58.76 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Lisa Levin]
Shares of Canadian Solar Inc. (NASDAQ: CSIQ) were down around 11 percent to $12.10 after the company posted downbeat quarterly earnings and issued a weak forecast.
- [By Chris Lange]
Canadian Solar Inc. (NASDAQ: CSIQ) is set to report its fourth-quarter results on Tuesday morning. The analysts consensus estimates call for earnings per share (EPS) of $0.32 and $690.27 million in revenue. Shares closed trading at $13.74 on Friday. The consensus price target is $15.21, and the 52-week trading range is $10.25 to $21.35.
- [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.
Hot Bank Stocks To Invest In Right Now: Alnylam Pharmaceuticals Inc.(ALNY)
- [By Lisa Levin]
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.
- [By Ben Levisohn]
Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.
- [By Cory Renauer]
Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.
- [By Chris Dier-Scalise]
On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.
- [By Brian Orelli]
Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.
Hot Bank Stocks To Invest In Right Now: Finisar Corporation(FNSR)
- [By Lisa Levin]
Finisar Corporation (NASDAQ: FNSR) shares were also up, gaining 18 percent to $16.70 after the company reported upbeat Q3 earnings.
Equities Trading DOWN
- [By Lisa Levin]
Shares of Foresight Autonomous Holdings ADR (NASDAQ: FNSR) were down 8 percent to $4.34. On Friday, Foresight posted Q3 non-GAAP net loss of $2,086,000, versus a year-ago non-GAAP net loss of $879,000.
- [By Renu Singh]
Finisar’s (FNSR) datacom segment generated $184.4 million in revenue in the last reported quarter. This was a sequential growth of 9.3%. The Ten Gigabit Ethernet or 10GbE modules contributed about 40% to the datacom segment’s revenue. As organizations go digital, there are an increasing number of applications that require considerable bandwidth to support the transfer of large data, video, and audio files across networks. Using 10GbE optical links provides sufficient bandwidth to support these bandwidth-intensive applications at a lower cost.
- [By Peter Graham]
Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is themostshorted stock on theNASDAQ with short interest of 62.65% according to Highshortnterest.com.
- [By Anders Bylund]
Shares of Finisar (NASDAQ:FNSR) rose 13.2% in February 2017, according to data from S&P Global Market Intelligence.
The bulk of Finisar’s February surge started when chief rival Lumentum (NASDAQ:LITE) delivered a strong earnings surprise, followed by several rosy analyst reviews. Lumentum’s solid results led investors to optimistic conclusions about the many target markets these two companies have in common, and Finisar’s gains nearly matched Lumentum’s post-earnings surge.
Hot Bank Stocks To Invest In Right Now: Platinum Group Metals Ltd.(PLG)
- [By William Patalon III]
Our sub-$2 “Gold Market Anomaly” play – Platinum Group Metals Ltd. (NYSE: PLG) – took a hit of more than 12% Wednesday after the miner raised $20 million through a stock offering.
Hot Bank Stocks To Invest In Right Now: DarioHealth Corp. (DRIO)
- [By Jim Robertson]
On Tuesday, our Under the Radar Moversnewsletter suggested going long small cap digital health (mHealth) stock DarioHealth Corp (NASDAQ: DRIO):
The entry here is rooted in the rebound’s “second wind,” which materialized today. You can see the late-Janaury/early-February rally was nice, but went too far, too fast. Sure enough, the profit-takers dug in. There weren’t a ton of profit-takers though – there was just a distinct lack of buyers. The next wave of buyers are diving in today, seeing last week’s support at the 20-day moving average line. We know there are more buyers than sellers here because today’s sizeable gain is unfurling on huge volume.